Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ohtsu

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Leukemia & Lymphoma|August 23, 2000
Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The lenograstim/Lymphoma Study GroupK Itoh, T Ohtsu, Y Sasaki, et al.
British Journal of Cancer|July 17, 1998
A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancerM Ando, T Watanabe, Y Sasaki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanesN Saijo, K Nishio, S Ohta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II studyT Igarashi, Y Kobayashi, M Ogura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505K Itoh, T Ohtsu, H Fukuda, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Leukemia & Lymphoma|August 23, 2000
Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The lenograstim/Lymphoma Study GroupK Itoh, T Ohtsu, Y Sasaki, et al.
British Journal of Cancer|July 17, 1998
A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancerM Ando, T Watanabe, Y Sasaki, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanesN Saijo, K Nishio, S Ohta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II studyT Igarashi, Y Kobayashi, M Ogura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505K Itoh, T Ohtsu, H Fukuda, et al.
Pageof 7